Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
774 NeoPOWER: A phase II study of neoadjuvant PD-1 blockade with cemiplimab in high risk localized, locally recurrent and regionally advanced cutaneous squamous cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
